SLAMF7 regulates the inflammatory response in macrophages during polymicrobial sepsis

Area of Science:

• Immunology
• Molecular Biology
• Pathophysiology

Background:

• Sepsis-induced uncontrolled inflammation leads to organ injury and mortality.
• Mechanisms regulating excessive inflammation in sepsis remain incompletely understood.

Purpose of the Study:

• To identify key regulators of inflammation during sepsis.
• To investigate the role of signaling lymphocyte activation molecular family 7 (SLAMF7) in sepsis-associated inflammation.

Main Methods:

• Analysis of SLAMF7 expression in sepsis patients and mice.
• Investigating SLAMF7's interaction with SHIP1 and TRAF6 in macrophages.
• Assessing the impact of SLAMF7 on TLR-dependent signaling pathways (MAPK, NF-κB).
• Evaluating the protective effects of SLAMF7 in lethal sepsis models.

Main Results:

• SLAMF7 expression is upregulated on monocytes/macrophages in sepsis.
• SLAMF7 attenuates TLR-dependent MAPK and NF-κB signaling via SHIP1.
• SLAMF7 inhibits K63 ubiquitination of TRAF6 by interacting with SHIP1 and TRAF6.
• Tyrosine phosphorylation sites on SLAMF7 and SHIP1 are crucial for these interactions and regulatory functions.
• SLAMF7 protects against lethal sepsis by reducing pro-inflammatory cytokines and organ damage.

Conclusions:

• SLAMF7 acts as a critical suppressor of inflammation in polymicrobial sepsis.
• SLAMF7's mechanism involves modulating macrophage signaling and cytokine production.
• SLAMF7 represents a potential therapeutic target for sepsis treatment.